The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Work Placement Inclusion 2022
Since 2012, Invest for children has been committed to the labor inclusion of people with intellectual disabilities through the Aura Fundación project. Aura Fundación was the first “Supported Employment” program…
see project 
